Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
China and India Play to Different Strengths
10:30 AM MDT | October 30, 2007 | DR
India and China are both rated as low-cost production bases for pharmaceuticals, but some international pharma companies believe the two countries do not compete directly with each other. Hiremath: India far ahead of China Generic drugs manufacturer Actavis (Hafnarfjordur, Iceland) acquired the active pharmaceutical ingredients (API) division of Sanmar Specialty Chemicals (Chennai, India) earlier this year, and has also been expanding in China. Actavis says that each country has an important role to play in the company’s growth. “We believe that costs...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee